Efung Capital
Overview
Efung Capital is a venture capital firm based in Shenzhen, China that focuses on VC and PE investments in the healthcare, life science, innovative drugs, and high-end medical device sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Zhejiang Barty Medical Technology | Jun 2026 | Series D | Co-investor |
| Chengdu NewRT Medical Technology | Apr 2026 | Series E | Co-investor |
| Shanghai Bendao Gene Technology | Apr 2026 | Strategic | Lead |
| Kind Pharmaceuticals | Nov 2025 | Series C | Co-investor |
| Kind Pharmaceutical | Nov 2025 | Series C | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Efung Capital based?
Efung Capital is headquartered in Shenzhen, Guangdong, China.
When was Efung Capital founded?
Efung Capital was founded in 2007.
How many portfolio companies does Efung Capital have?
Efung Capital has 29 portfolio companies in Caplight's dataset.
What are some companies in Efung Capital's portfolio?
Recent investments visible on Caplight include Zhejiang Barty Medical Technology, Chengdu NewRT Medical Technology, Shanghai Bendao Gene Technology, Kind Pharmaceuticals, Kind Pharmaceutical.
What was Efung Capital's most recent investment?
Efung Capital's most recent investment on Caplight was in Zhejiang Barty Medical Technology in 2026.
What sectors does Efung Capital focus on?
Efung Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Frontier & Industrial Tech, Enterprise Software, Mobility, Transportation & Logistics, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Efung Capital focus on?
Stage focus information for Efung Capital is not publicly available.
What is Efung Capital's AUM?
Efung Capital's assets under management are estimated between $100.0M and $250.0M.